Outset Medical
162 hedge funds and large institutions have $957M invested in Outset Medical in 2023 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 41 reducing their positions, and 19 closing their positions.
132% more call options, than puts
Call options by funds: $723K | Put options by funds: $311K
74% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 19
41% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 41
7% more funds holding
Funds holding: 151 → 162 (+11)
0.38% more ownership
Funds ownership: 6.75% → 7.13% (+0.38%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less capital invested
Capital invested by funds: $1.26B → $957M (-$305M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$18.6M |
| 2 |
PVI
Pura Vida Investments
New York
|
+$11.4M |
| 3 |
JP Morgan Chase
New York
|
+$10.3M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$7.95M |
| 5 |
Millennium Management
New York
|
+$7.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$10.2M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$7.33M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$5.52M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5.14M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$4.81M |
OM Hedge Fund Activity: Q1 2023 in Review
162 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2023, worth a combined $957M — down 24% from $1.26B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new OM positions and 19 closed out — a net gain of 14 holders — while 58 added to existing stakes and 41 trimmed.
The largest buyer was Ameriprise, adding an estimated $18.6M. The largest seller was Barclays, cutting an estimated $10.2M.
- 162 institutional investors held Outset Medical (OM) as of Q1 2023, up from 151 in Q4 2022.
- Funds reported $957M of Outset Medical stock for Q1 2023, down 24% quarter-over-quarter.
- 33 funds opened new Outset Medical positions in Q1 2023 and 19 closed out, a net change of +14 holders.
- The largest Outset Medical buyer in Q1 2023 was Ameriprise, an estimated $18.6M added.
- The largest Outset Medical seller in Q1 2023 was Barclays, an estimated $10.2M sold.
Based on aggregated 13F filings for Q1 2023.